Table 1 Body weight and biochemical measurements at 20th week.
From: The effects of the voglibose on non-alcoholic fatty liver disease in mice model
Chow | HFHFr | HFHFr-V | HFHFr-P | |
|---|---|---|---|---|
Body weight (g) | 27.0 ± 0.9 | 38.2 ± 3.4# | 33.0 ± 2.8#† | 35.0 ± 2.0# |
Liver weight (g) | 1.1 ± 0.1 | 3.0 ± 0.7# | 1.8 ± 0.4#† | 2.6 ± 0.4#* |
Liver to body weight (%) | 4.2 ± 0.1 | 7.9 ± 1.2# | 5.3 ± 0.7#† | 7.4 ± 0.8#* |
AST (IU/L) | 82.6 ± 17.4 | 463.8 ± 250.8# | 154.2 ± 66.1† | 288.4 ± 96.8 |
ALT (IU/L) | 26.0 ± 6.4 | 487.0 ± 303.1# | 114.6 ± 88.8† | 255.6 ± 99.7 |
Fasting glucose (mg/dL) | 133.6 ± 27.8 | 235.8 ± 118.4 | 177.0 ± 75.5 | 184.1 ± 31.8 |
Fasting insulin (ng/dL) | 0.34 ± 0.02 | 0.25 ± 0.004# | 0.25 ± 0.01# | 0.26 ± 0.004# |
HOMA-IR | 2.8 ± 0.6 | 3.7 ± 1.9 | 2.4 ± 0.9 | 2.9 ± 0.5 |
